Media center

At PATH, our global health experts are developing partnerships, new devices, and solutions to the world's most pressing health needs. Contact us to speak with one of PATH's experts today.

Contact Us

Senior Director of Marketing & Communications:
Lauren Grella

Email: media@path.org

Recent Press Coverage

  1. Inspired by Ares Management's Pathfinder initiative, Promote Giving signatories have committed to donating the equivalent of at least 5% of their selected funds’ performance fees to charities.
    Published: October 2025
  2. Kenya has reaffirmed its commitment to advancing Universal Health Coverage (UHC) through stronger collaboration with PATH focused on sustainable health solutions anchored in local innovation and manufacturing capacity.
    Published: September 2025
  3. PATH’s Nikolaj Gilbert and Dame Sally Davies write in The Telegraph about drug-resistant infections that are outpacing our ability to treat them—and how the global community must come together to address this growing global threat.
    Published: March 2025
  4. PATH is among the global partners receiving funding from the GHIT Fund’s $12.7 million investment to advance new diagnostics and drug development for malaria and neglected tropical diseases (NTDs).
    Published: January 2025

We develop evidence-based expertise and resources

Our global team leverages data and evidence to develop resources and innovations that bring good health to more people.

Explore our evidence

Join the latest discussions on health equity.

We partner with the public and private sector, government, and academia from around the world to share insightful conversations on the latest topics affecting health equity.

Explore PATH events

PATH Newsroom

Related articles

Read our latest

968 Item s
968 Item s
    Date
    From
    To
  1. Point-of-care diagnostics for G6PD deficiency, a common hereditary condition, play a critical role in supporting the appropriate treatment of Plasmodium vivax malaria
    Published: October 2020
    Press Release
  2. The newly updated HEROES Act not only proposes support for COVID-19 pandemic response in the United States, but also adds critical emergency funding for global health programs.
    Published: October 2020
    Press Release
  3. A grant from the GHIT Fund will support partners in the United States and Japan to develop a new low-cost, broad spectrum anthelmintic protein Cry5B oral treatment option.
    Published: September 2020
    Press Release
  4. Published: September 2020
    Press Release
  5. Clinical specimen bank now includes convalescent plasma, creating more opportunity for affordable diagnostic development
    Published: September 2020
    Press Release